171 related articles for article (PubMed ID: 22551973)
1. Histology-specific microRNA alterations in melanoma.
Poliseno L; Haimovic A; Segura MF; Hanniford D; Christos PJ; Darvishian F; Wang J; Shapiro RL; Pavlick AC; Berman RS; Hernando E; Zavadil J; Osman I
J Invest Dermatol; 2012 Jul; 132(7):1860-8. PubMed ID: 22551973
[TBL] [Abstract][Full Text] [Related]
2. Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression.
Rose AE; Poliseno L; Wang J; Clark M; Pearlman A; Wang G; Vega Y Saenz de Miera EC; Medicherla R; Christos PJ; Shapiro R; Pavlick A; Darvishian F; Zavadil J; Polsky D; Hernando E; Ostrer H; Osman I
Cancer Res; 2011 Apr; 71(7):2561-71. PubMed ID: 21343389
[TBL] [Abstract][Full Text] [Related]
3. Defining the Prognostic Role of MicroRNAs in Cutaneous Melanoma.
Dika E; Riefolo M; Porcellini E; Broseghini E; Ribero S; Senetta R; Osella-Abate S; Scarfì F; Lambertini M; Veronesi G; Patrizi A; Fanti PA; Ferracin M
J Invest Dermatol; 2020 Nov; 140(11):2260-2267. PubMed ID: 32275975
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of prognostic factors in patients with nodular melanoma.
Susok L; Stücker M; Bechara FG; Stockfleth E; Gambichler T
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2759-2764. PubMed ID: 33630139
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma.
Satzger I; Mattern A; Kuettler U; Weinspach D; Voelker B; Kapp A; Gutzmer R
Int J Cancer; 2010 Jun; 126(11):2553-62. PubMed ID: 19830692
[TBL] [Abstract][Full Text] [Related]
6. Distinct Clinicopathological and Prognostic Features of Thin Nodular Primary Melanomas: An International Study from 17 Centers.
Dessinioti C; Dimou N; Geller AC; Stergiopoulou A; Lo S; Keim U; Gershenwald JE; Haydu LE; Ribero S; Quaglino P; Puig S; Malvehy J; Kandolf-Sekulovic L; Radevic T; Kaufmann R; Meister L; Nagore E; Traves V; Champsas GG; Plaka M; Dreno B; Varey E; Ramirez DM; Dummer R; Mangana J; Hauschild A; Egberts F; Peris K; Del Regno L; Forsea AM; Zurac SA; Vieira R; Brinca A; Zalaudek I; Deinlein T; Linos E; Evangelou E; Thompson JF; Scolyer RA; Garbe C; Stratigos AJ
J Natl Cancer Inst; 2019 Dec; 111(12):1314-1322. PubMed ID: 30863861
[TBL] [Abstract][Full Text] [Related]
7. Melanocytic nevi in histologic association with primary cutaneous melanoma of superficial spreading and nodular types: effect of tumor thickness.
Sagebiel RW
J Invest Dermatol; 1993 Mar; 100(3):322S-325S. PubMed ID: 8440914
[TBL] [Abstract][Full Text] [Related]
8. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA signatures differentiate melanoma subtypes.
Chan E; Patel R; Nallur S; Ratner E; Bacchiocchi A; Hoyt K; Szpakowski S; Godshalk S; Ariyan S; Sznol M; Halaban R; Krauthammer M; Tuck D; Slack FJ; Weidhaas JB
Cell Cycle; 2011 Jun; 10(11):1845-52. PubMed ID: 21543894
[TBL] [Abstract][Full Text] [Related]
10. Microrna profiling analysis of differences between the melanoma of young adults and older adults.
Jukic DM; Rao UN; Kelly L; Skaf JS; Drogowski LM; Kirkwood JM; Panelli MC
J Transl Med; 2010 Mar; 8():27. PubMed ID: 20302635
[TBL] [Abstract][Full Text] [Related]
11. An assessment of clinical pathways and missed opportunities for the diagnosis of nodular melanoma versus superficial spreading melanoma.
Cicchiello M; Lin MJ; Pan Y; McLean C; Kelly JW
Australas J Dermatol; 2016 May; 57(2):97-101. PubMed ID: 26563931
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of the histological subtype of melanoma on the hands and feet in Caucasians.
Carrera C; Gual A; Díaz A; Puig-Butillé JA; Noguès S; Vilalta A; Conill C; Rull R; Vilana R; Arguis P; Vidal-Sicart S; Alós L; Palou J; Castel T; Malvehy J; Puig S
Melanoma Res; 2017 Aug; 27(4):315-320. PubMed ID: 28296711
[TBL] [Abstract][Full Text] [Related]
13. Global microRNA profiling of metastatic conjunctival melanoma.
Mikkelsen LH; Andersen MK; Andreasen S; Larsen AC; Tan Q; Toft PB; Wadt K; Heegaard S
Melanoma Res; 2019 Oct; 29(5):465-473. PubMed ID: 30932942
[TBL] [Abstract][Full Text] [Related]
14. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
15. Association of tumor and plasma microRNA expression with tumor monosomy-3 in patients with uveal melanoma.
Triozzi PL; Achberger S; Aldrich W; Crabb JW; Saunthararajah Y; Singh AD
Clin Epigenetics; 2016; 8():80. PubMed ID: 27453764
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative and Pro-Apoptotic Effects of MiR-4286 Inhibition in Melanoma Cells.
Komina A; Palkina N; Aksenenko M; Tsyrenzhapova S; Ruksha T
PLoS One; 2016; 11(12):e0168229. PubMed ID: 28005927
[TBL] [Abstract][Full Text] [Related]
17. Five-year survival in patients with nodular and superficial spreading melanomas in the US population.
Allais BS; Beatson M; Wang H; Shahbazi S; Bijelic L; Jang S; Venna S
J Am Acad Dermatol; 2021 Apr; 84(4):1015-1022. PubMed ID: 33253834
[TBL] [Abstract][Full Text] [Related]
18. Association of Skin Examination Behaviors and Thinner Nodular vs Superficial Spreading Melanoma at Diagnosis.
Dessinioti C; Geller AC; Stergiopoulou A; Swetter SM; Baltas E; Mayer JE; Johnson TM; Talaganis J; Trakatelli M; Tsoutsos D; Tsourouflis G; Stratigos AJ
JAMA Dermatol; 2018 May; 154(5):544-553. PubMed ID: 29710122
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of malignant melanoma according to subtype.
Lin MJ; Mar V; McLean C; Wolfe R; Kelly JW
Australas J Dermatol; 2014 Feb; 55(1):35-42. PubMed ID: 24283461
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs expression associated with aggressive clinicopathological features and poor prognosis in primary cutaneous melanomas.
Murria Estal R; de Unamuno Bustos B; Pérez Simó G; Simarro Farinos J; Torres Navarro I; Alegre de Miquel V; Ballester Sánchez R; Sabater Marco V; Llavador Ros M; Palanca Suela S; Botella Estrada R
Melanoma Res; 2021 Feb; 31(1):18-26. PubMed ID: 33234848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
